Loading...
OTCM
BBBT
Market cap98kUSD
Nov 03, Last price  
0.00USD
Name

Black Bird Biotech Inc

Chart & Performance

D1W1MN
OTCM:BBBT chart
P/E
P/S
1.19
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
83k
-20.96%
000691,6001,116,880000000017,77157,604104,45882,563
Net income
-2m
L-8.42%
-36,063-23,253-168,723-8,272,310-160,159-86,515-89,991-99,519-112,470-106,268-110,014-121,110-163,628-691,570-1,811,302-1,658,766
CFO
-1m
L+4.05%
-691,236-35,963-23,128-159,948-731,018167,821-67,166-78,481-81,556-80,173-77,942-75,690-76,098-86,325-619,465-992,428-1,032,574

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Black Bird Biotech Inc. operates within the biotechnology sector, offering a diverse array of products. A key offering is MiteXstream, a unique plant-derived biopesticide manufactured and distributed by the company, specifically formulated to eradicate spider mites. The company further diversifies its portfolio with a range of consumer goods sold under its Grizzly Creek Naturals brand. These include CBD oils, gummies, and pet treats, as well as CBD-infused personal care items and both gel and spray hand sanitizer products. Beyond these offerings, Black Bird Biotech also engages in the cultivation of industrial hemp, participating in the Montana Hemp pilot program. The entity, headquartered in Flower Mound, Texas, underwent a name change in June 2021, transitioning from its former identity as Digital Development Partners, Inc. to its current Black Bird Biotech, Inc. designation.
IPO date
Dec 10, 2007
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT